Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

The Vaginal Microbiota of Adult Malagasy Women of Reproductive Age in the Marovoay District: First Characterization and Exploration of Associations With Human Papillomavirus and Schistosoma haematobium Infections

Jana Christina Hey, Johanna Saalfrank, Tahinamandranto Rasamoelina, Anjarasoa Ravo Razafindrakoto, Matthieu Razafindralava, Valeri Gildas Rajaoniarivo, Jean Marc Kutz, Sonya Ratefiarisoa, Thorsten Thye, Irina Kislaya, Simon Graspeuntner, Zoly Rakotomalala, Bodo Sahondra Randrianasolo, Rivo Solotiana Rakotomalala, Valentina Marchese, Raphael Rakotozandrindrainy, Diavolana Koecher-Andrianarimanana, Pia Rausche, Aaron Remkes, Jürgen MayPytsje T. Hoekstra, Govert J. van Dam, Paul L.A.M. Corstjens, Tarik Gheit, Rivo Andry Rakotoarivelo, Corinna Bang, Daniela Fusco*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background: The vaginal microbiome plays an important role for women's health. Changes in its composition have been associated with several sexually transmitted infections, including human papillomavirus (HPV) or parasitic infections such as Schistosoma haematobium. In Madagascar, gynecological conditions such as chronic manifestations of S. haematobium infections (female genital schistosomiasis), HPV infections, and cervical cancer are highly prevalent; however, data on the interplay between these conditions and the vaginal microbiota (VM) are still scarce. In addition, the majority of data originates from the Global North, generating a biased understanding of “healthy” VM across different geographic and social contexts. The objective of our study was to characterize for the first time the VM of adult women of reproductive age in Madagascar and to describe the variability of the vaginal environment in the presence of 3 conditions affecting the urogenital tract. Methods and Results: We characterized the VM of 443 participants, identifying the 5 community state types (CSTs I–V), with CST IV (57.1%, diverse) and CST III (34.1%, Lactobacillus iners dominated) as the most prevalent. CSTs were associated with previous antibiotics usage, while variability in the alpha and beta diversity was associated with dietary behavior and previous antibiotic usage. Differential abundance analysis showed variations among specific taxa in HPV-positive and female genital schistosomiasis–positive participants. Conclusions: With this first study of the VM in Madagascar we contribute to a broader understanding of vaginal health, as well as narrowing the gap of VM research in sub-Saharan Africa by enriching microbiota databases.

OriginalspracheEnglisch
ZeitschriftJournal of Infectious Diseases
Jahrgang234
Ausgabenummer1
Seiten (von - bis)e90-e100
ISSN0022-1899
DOIs
PublikationsstatusVeröffentlicht - 15.07.2026

Fördermittel

Financial support. This work was supported by the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD, a program of the Task Force for Global Health) through the project FIRM-UP (project no. NTDSC 210D); by the German Centre for Infection Research (DZIF) through the project NAMASTE (project no. 8008803819) and VAMS (MD program TI 07.003); and by the DFG Excellence Cluster 2167 “Precision Medicine in Chronic Inflammation” (PMI) and the DFG Research Unit 5042 “miTarget” (infrastructure support for 16S rRNA gene amplicon sequencing). Acknowledgments.We thank the study participants, without whom this work would not have been possible, as well as the field staff, including drivers, data clerks, and community workers. We thank all the donors who contributed to the success of this study. Special thanks to all the country authorities who allowed and supported the implementation of the study.Author contributions. D. F. conceptualized the study. J. C. H. and D. F. conceptualized the data analysis plan, and data analysis was performed by J. C. H. under the supervision of T. T., I. K., S. G., and C. B. Field implementation was coordinated by T. R., V. M., R. R., D. K. A., R. A. R., and D. F. and performed by A. R. R., M. R., V. G. R., J. M. K., S. R., Z. R., B. S. R., R. S. R., and A. R. Data management was performed by P. R. Acquisition of sequencing data was performed by J. S., under the supervision of C. B. HPV diagnostics were performed by T. G. Schistosome diagnostics were performed by M. R., under the supervision of P. T. H., G. J. v. D., and P. L. A. M. C., who also produced the testing material. Funds were mostly acquired by D. F., with the contribution of J. M. All authors revised and approved the manuscript before submission.Disclaimer.Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article, and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer/World Health Organization.Data availability. The datasets generated and/or analyzed during the current study are available in the European Nucleotide Archive repository (project accession no. PRJEB96883; data available on publication). Additional datasets used during the current study are available from the corresponding author on reasonable request and will be freely available to researchers who wish to use them for noncommercial purposes, without breaching the confidentiality of participants. Financial support.This work was supported by the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD, a program of the Task Force for Global Health) through the project FIRM-UP (project no. NTDSC 210D); by the German Centre for Infection Research (DZIF) through the project NAMASTE (project no. 8008803819) and VAMS (MD program TI 07.003); and by the DFG Excellence Cluster 2167 “Precision Medicine in Chronic Inflammation” (PMI) and the DFG Research Unit 5042 “miTarget” (infrastructure support for 16S rRNA gene amplicon sequencing).

TrägerTrägernummer
DFG Excellence Cluster 2167 “Precision Medicine in Chronic Inflammation” (PMI)
DFG Research Unit 5042 “miTarget”
Task Force for Global HealthNTDSC 210D
Deutsches Zentrum für InfektionsforschungTI 07.003, 8008803819, MD program TI 07.003

    UN SDGs

    Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

    1. SDG 3 – Gesundheit und Wohlergehen
      SDG 3 – Gesundheit und Wohlergehen
    2. SDG 6 – Sauberes Wasser und sanitäre Einrichtungen
      SDG 6 – Sauberes Wasser und sanitäre Einrichtungen

    Strategische Forschungsbereiche und Zentren

    • Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

    Fingerprint

    Untersuchen Sie die Forschungsthemen von „The Vaginal Microbiota of Adult Malagasy Women of Reproductive Age in the Marovoay District: First Characterization and Exploration of Associations With Human Papillomavirus and Schistosoma haematobium Infections“. Zusammen bilden sie einen einzigartigen Fingerprint.

    Zitieren